• Return to search results
• Start new search

Investigator(s):
Nancy M. Hardy, M.D. Principal Investigator Phone: 301-451-1406 hardyn@mail.nih.gov
Referral Contact(s):
Zetta Blacklock, R.N., B.S., B.S.N. Transplant Coordinator Phone: 301-594-2056 Fax: 301-451-5578 bblacklock@mail.nih.gov	Sheila Phang, R.N., M.S. Transplant Coordinator Phone: 301-435-9379 Fax: 301-451-5578 sphang@mail.nih.gov

---

Key Eligibility Criteria:

• Individuals from one of the following groups:
• Have received an allotransplant for hematologic malignancies (blood system cancer) and have disease progression or recurrence
• Have received an allotransplant for hematologic malignancies (blood system cancer) and in remission 100 days or more after receiving allotransplant treatment
• Individuals who are candidates for allotransplant therapy for hematologic malignancies and are being evaluated at the Clinical Center for planned allotransplantation
• Related stem-cell donors of eligible allotransplant recipients
• Age 0–99 years of age

---

Study Outline:

• Recipient/participants with relapse will have clinical and research evaluations at baseline and at 6, 12 and 24 months post-allotransplant, then yearly; evaluation after relapse treatment response and for new protocol options is permitted
• Recipient/participants in remission will have clinical and research evaluations at baseline and 6, 12 and 24 months post-allotransplant; evaluation for new protocol options, e.g., for relapse, is permitted
• Pre-transplant participants will have clinical and research evaluations at baseline and at three months post-allotransplant, thereafter per cohort assignment
• Donor/participants will undergo a clinical evaluation and cell collection for recipient/participant therapy and research; return evaluation for additional clinical product collection is permitted

---

Additional Information:

• This trial will be conducted at the NIH Clinical Center in Bethesda, MD. It is open to patients who meet the eligibility requirements, regardless of where they live in the United States.
• There is no charge for medical care received at NIH Clinical Center.
• FAQs about this study - provides information for patients about the trial such as frequency and duration of visits, costs, how to enroll, and study outline.
• PDQ (Physicians Data Query) - provides additional details about this study for health care providers.

Reviewed: 9/6/12
Updated: 10/1/12